TYK MEDICINES-B (02410) has announced that the company applied to the Stock Exchange's listing committee for approval to list and trade 4.608 million H-shares. These shares were converted from 4.608 million non-listed shares held by one of the company's shareholders. The Stock Exchange granted the listing approval on February 11, 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments